Navigation Links
arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
Date:4/24/2013

BREDA, The Netherlands and GHENT, Belgium, April 24, 2013 /PRNewswire/ --

First program based on proprietary ABDEG™ technology to promote degradation and clearance of disease-causing autoantibodies

arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed its second product candidate this year into formal preclinical development.

Complementing its existing pipeline of four human mAb-based programs, arGEN-X has   developed ARGX-113 as a human antibody Fc fragment. Exploiting its novel, proprietary technology called ABDEG™, ARGX-113 has been designed to clear and degrade circulating disease-causing autoantibodies. As arGEN-X' first ever ABDEG development program, ARGX-113 is an exciting and novel approach to treating potentially any IgG-mediated autoimmune disease. Such indications could include major autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, as well as a wide range of serious, orphan diseases for which there are currently insufficient treatment options, such as myasthenia gravis and immune thrombocytopenic purpura.  

Development of ARGX-113 was based on preclinical studies originally conducted in the research group of Professor Sally Ward at the University of Texas Southwestern Medical Center, from which arGEN-X licensed the ABDEG technology in 2012. Data generated in Professor Ward's laboratory showed the ability of ABDEGs to markedly reduce inflammation in both preventative and established models of rheumatoid arthritis. Further preclinical studies of ARGX-113 are now being undertaken by arGEN-X, with an IND filing anticipated in 2015.

Tim Van Hauwermeiren, CEO of arGEN-X, said: "The therapeutic potential of ARGX-113 in multiple autoimmune diseases
'/>"/>

SOURCE arGEN-X
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
2. Nabsys to Present DNA Sequence Data from Solid-State Nanodetectors at the Annual Advances in Genome Biology and Technology (AGBT) Meeting and the EMBL Omics and Personalized Health Conference
3. UWM discovery advances graphene-based electronics
4. Next-generation nanoelectronics: A decade of progress, coming advances
5. New metamaterial practical for optical advances
6. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
7. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
8. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
9. Collegiate Inventors Honored for Innovative Science and Technology Advances
10. Computer memory could increase fivefold from advances in self-assembling polymers
11. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 27, 2015 Research and Markets( http://www.researchandmarkets.com/research/l9dqwt/animal_genetics ) ... Market by Products, by Testing services - Global Forecast ... The global animal genetics market is estimated to be ... a CAGR of 8-9% during the forecast period of ... driven by increasing animal protein consumption, increasing adoption of ...
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/3nl6s2/neuroprotection ) has ... "Neuroprotection - Drugs, Markets and Companies" ... the role of neuroprotection in acute disorders such ... as well as in chronic diseases such as ... of damage to neural tissues are similar in ...
(Date:5/28/2015)... May 28, 2015 Celsion Corporation (the "Company") ... received commitments from two institutional healthcare investors to purchase ... common stock in an at-the-market registered direct offering and ... stock. The Company entered into a definitive ... Company agreed to sell an aggregate of 3,000,000 shares ...
(Date:5/28/2015)... 28, 2015 DryLet, LLC a ... applications such as animal waste reduction, bioremediation, wastewater ... in wastewater treatment plants and restaurant kitchen settings, ... Pork Expo, June 3-5 in Des Moines, Iowa. ... a Wall Street Journal article because of its ...
Breaking Biology Technology:Global Animal Genetics (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material) Market 2015 - Global Forecast to 2020 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3DryLet to Showcase Patented ManureMagicâ„¢ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2
... /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine ... 3-year research agreement with Defence Research and Development ... application of IVT,s DepoVax(TM) vaccine formulation to anthrax ... for, and respond to biological threats. , "Dr. ...
... from Colorectal Cancer and Oral Picoplatin Trials To Be ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... will present final data from two Phase 1 clinical ... poster sessions during the American Association for Cancer Research ...
... Zenobia Therapeutics, Inc., the leader in fragment-based lead ... announced successful completion of the first phase of ... subsidiary of Biogen Idec (Nasdaq: BIIB ... access to Zenobia,s technology and expertise in structural ...
Cached Biology Technology:ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats 2Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting 2Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals 2
(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/21/2015)... 21, 2015 According to ... Solutions (Hardware, Software, Services), by Applications (Surveillance (Airborne, ... by End-Users (Military & Defense & Commercial) - ... Imaging Market is expected to grow from $7252.0 ... at a Compound Annual Growth Rate (CAGR) of ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... hosting a lecture and symposium Tuesday, March 10, through ... disastrous floods of summer 2008. "Living With Floods: ... symposium in The Forkenbrock Series on Public Policy. National ... floods to the psychological impact of displacement, from flood ...
... infection by intestinal worms a condition that affects more ... the immune system is more versatile than has long been ... of exploration in the search for treatments against autoimmune diseases ... own tissues. The findings, reported by scientists who performed ...
... about how to "grow your own organs" using stem cells ... has been elusive. A new report published in the March ... ) brings bioengineered organs a step closer, as scientists from ... they were able to use a "scaffolding" material extracted from ...
Cached Biology News:Public Policy Center hosts flood symposium March 10-12 2A worm-and-mouse tale: B cells deserve more respect 2A worm-and-mouse tale: B cells deserve more respect 3From stem cells to new organs: Stanford and NYU scientists cross threshold in regenerative medicine 2
Rabbit polyclonal to JAK1 (phospho Y1022 + Y1023) ( Abpromise for all tested applications). entrezGeneID: 3716 SwissProtID: P23458...
Complete PCR kit. Includes: MasterAmp™ Taq DNA Polymerase, 10X PCR Buffer, MasterAmp™ 10X PCR Enhancer, dNTP Mix, 2.5 mM each, 25 mM MgCl2, Enzyme Dilution Buffer, Control Template and Prim...
Request Info...
The FailSafe™ PROBES Real-Time PCR System enables rapid, precise optimization of PCR experiments in which the product is detected using fluorescent target-specific labeled probes....
Biology Products: